Lineage Cell Therapeutics Inc (LCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2003 | 03-2003 | 12-2002 | 09-2002 | 06-2002 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,506 | -751 | -2,845 | -2,069 | -1,490 |
| Depreciation Amortization | 348 | 155 | 507 | 361 | 230 |
| Accounts receivable | -3 | N/A | N/A | N/A | N/A |
| Other Working Capital | 359 | -3 | 74 | 14 | 133 |
| Other Operating Activity | 81 | 39 | 135 | 78 | -25 |
| Operating Cash Flow | $-721 | $-561 | $-2,129 | $-1,616 | $-1,152 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | -4 | N/A | N/A |
| Investing Cash Flow | $N/A | $N/A | $-4 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 87 | N/A | 2,075 | 2,075 | N/A |
| Other Financing Activity | 0 | 0 | -310 | -282 | 0 |
| Financing Cash Flow | $87 | $N/A | $1,765 | $1,793 | $N/A |
| Beginning Cash Position | 1,284 | 1,284 | 1,653 | 1,653 | 1,653 |
| End Cash Position | 650 | 724 | 1,284 | 1,829 | 501 |
| Net Cash Flow | $-634 | $-561 | $-368 | $176 | $-1,152 |
| Free Cash Flow | |||||
| Operating Cash Flow | -721 | -561 | -2,129 | -1,616 | -1,152 |
| Free Cash Flow | -721 | -561 | -2,129 | -1,616 | -1,152 |